Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors
This study has been completed.
Sponsor:
Herbert Hurwitz
Collaborators:
Novartis
Genentech
Information provided by (Responsible Party):
Herbert Hurwitz, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01055795
First received: January 24, 2010
Last updated: December 21, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2012 |
| Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |